Inventor · disambiguated record
Masaomi Tajimi
Also filed as: TAJIMI MASAOMI · ZIEGELBAUER KARL
14 granted patents·16 pending applications·34 citations·filing 2000–2021
88Inventor score
Top patents by PatentIndex Score
30 records- 0174US10512635B2Uses of benzimidazole derivative for nocturnal acid breakthroughCJ HEALTHCARE CORP·Filed 2016·Granted Dec 24, 2019·1 cites·13 claims
- 0274US7381840B2Tetrahydro-naphthalene derivativesXENTION LTD·Filed 2003·Granted Jun 3, 2008·7 cites·8 claims
- 0373US7615557B2Tetrahydro-naphthalene and urea derivativesXENTION LTD·Filed 2004·Granted Nov 10, 2009·9 cites·26 claims
- 0472US7544716B2Tetrahydro-naphthalene derivatives as vanilloid receptor antagonistsXENTION LTD·Filed 2003·Granted Jun 9, 2009·6 cites·7 claims
- 0570US7612113B2Hydroxy tetrahydro-naphthalenylurea derivativesXENTION LTD·Filed 2003·Granted Nov 3, 2009·6 cites·19 claims
- 0668US7423175B2Hydroxy-tetrahydro-naphthalenylurea derivativesBAYER HEALTHCARE AG·Filed 2004·Granted Sep 9, 2008·4 cites·17 claims
- 0765US8173841B2Tetrahydro-naphthalene derivativesTAJIMI MASAOMI·Filed 2011·Granted May 8, 2012·1 cites·10 claims
- 0861US2021179613A1Ghrelin receptor agonist for treatment of cachexiaRAQUALIA PHARMA INC·Filed 2021·Application pending·0 cites
- 0956US11033532B2Uses of benzimidazole derivative for nocturnal acid breakthroughHK INNO N CORP·Filed 2019·Granted Jun 15, 2021·0 cites·23 claims
- 1056US8088826B2Tetrahydro-naphthalene derivativesTAJIMI MASAOMI·Filed 2008·Granted Jan 3, 2012·0 cites·10 claims
- 1154US2009209514A1Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor AntagonistsTAJIMI MASAOMI·Filed 2009·Application pending·0 cites
- 1252US7683076B2Tetrahydro-quinolinylurea derivativesBAYER SCHERING PHARMA AG·Filed 2004·Granted Mar 23, 2010·0 cites·15 claims
- 1349US2004229859A1Beta-amino acid compounds as integrin antagonistsBAYER AG·Filed 2004·Application pending·0 cites
- 1448US10975070B2Ghrelin receptor agonist for treatment of cachexiaSHIMADA KAORU·Filed 2011·Granted Apr 13, 2021·0 cites·8 claims
- 1546US2008058377A1Bicyclic Amide, Carbamate or Urea Derivatives as Vanilloid Receptor ModulatorsBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 1646US2005222247A1Chroman derivativesBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 1743US2006183753A1Use of substituted 2,5-diamidoindoles for the treatment of urological diseasesBAYER HEALTHCARE AG·Filed 2003·Application pending·0 cites
- 1843US2008045546A1Tetradydro-Naphthalene And Urea DerivativesBOUCHON AXEL·Filed 2004·Application pending·0 cites
- 1942US6794386B2β-amino acid compounds as integrin antagonistsBAYER AG·Filed 2000·Granted Sep 21, 2004·0 cites·6 claims
- 2041US2010137361A1Tetrahydro-Quinolinylurea DerivativesBAYER SCHERING PHARMA AG·Filed 2010·Application pending·0 cites
- 2141US2005176010A1Regulation of human transient receptor potential channelBAYER HEALTHCARE AG·Filed 2003·Application pending·0 cites
- 2241US2006166989A12-naphthamide derivativesBAYER HEALTHCARE AG·Filed 2003·Application pending·0 cites
- 2340US2006135613A1Carboxamides derivativesBAYER HEALTHCARE AG·Filed 2003·Application pending·0 cites
- 2439US7064229B2Succinic acid derivativesBAYER HEALTHCARE AG·Filed 2002·Granted Jun 20, 2006·0 cites·11 claims
- 2539US2005154230A1Urea derivativesBAYER HEALTHCARE AG·Filed 2002·Application pending·0 cites
- 2637US7091242B2Beta-amino acid derivatives as integrin receptor antagonistsBAYER AG·Filed 2001·Granted Aug 15, 2006·0 cites·11 claims
- 2737US2005119304A1Urea derivativesFiled 2002·Application pending·0 cites
- 2837US2005054582A1Para-amino benzoic acids as integrin antagonistsFiled 2002·Application pending·0 cites
- 2937US2004259875A1Amine derivativesFiled 2002·Application pending·0 cites
- 3035US2003232868A1Cyclic carboxylic acids as integrin antagonistsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masaomi Tajimi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →